Abstract:www.ccmjournal.org March 2013 • Volume 41 • Number 3 Aspiration is a common complication in hospitalized patients, which is usually associated with poor outcomes, especially in those with neuromuscular diseases, gastrointestinal or esophageal dysfunction, and loss of consciousness. The clinical manifestations of aspiration vary depending on volume and contents of aspiration as well as the host’s response. Considering quick deterioration of lung function due to chemical and bacterial insults after aspiration, it is critical to have an assay to detect and discriminate chemical and bacterial pneumonia to guide antibiotic treatment. Several biomarkers, such as pepsin and lipid laden alveolar macrophages have been identified as evidence of aspiration because both of them suggested lipid content from gastrointestinal tract, especially in children with gastro esophageal reflux and gastric contents aspiration–induced bronchopulmonary dysplasia in neonates (1). In adults patients, bronchoalveolar lavage (BAL) pepsin in intubated patients has been considered an indicator for aspiration of gastric contents and also a major risk factor for pneumonia (2, 3). To further diagnose etiology of aspiration pneumonia, serum procalcitonin (PCT), C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 (sTERM-1), and cytokines profiles (4) have been investigated for feasibility to discriminate bacterial aspiration pneumonia and chemical pneumonitis besides as a marker to diagnose aspiration. In addition, serial measurements of serum PCT was associated with the prognosis of pulmonary aspiration (5) and BAL sTREM-1 levels could be potentially useful in distinguishing BAL culture–positive from BAL culture–negative aspiration (6). However, both the sensitivity and specificity (76% and 38% for PCT using a threshold of 2.0 ng/ml, 65.8% and 91.9% for sTREM-1 using a threshold of 250 pg/ml) to diagnose aspiration pneumonia and chemical pneumonitis using above biomarker have not been widely accepted. In this issue of Critical Care Medicine, Weiss and colleagues (7) studied the role of BAL α-amylase in diagnosis of aspiration in a retrospective study. Total 296 BAL samples were collected within 72 hrs after endotracheal intubation from 280 mechanically ventilated patients in five medical centers, and the relationship between BAL amylase concentration and pre-intubation aspiration risk factors as well as the BAL microbial culture results were analyzed. What they found were 1) there was a strong association between BAL amylase concentration and traditional risk factors for aspiration; 2) BAL amylase concentration may predict bacterial pneumonia; 3) if BAL amylase concentration cutoff value was < 125 units/L, the sensitivity for predicting bacterial pneumonia was 70%, with a negative predictive value of 85%. If combined with clinical information, BAL amylase might be helpful in early diagnosis and the management of suspected aspiration. Actually, as early as in the 1980s, there was some evidence showing (8, 9) that BAL amylase was derived from oropharyngeal contents and aspiration or pulmonary complication. Unfortunately, no further clinical studies have been conducted to confirm above findings until Weiss et al revealed the significance of BAL amylase in diagnosing and differentiating bacterial pneumonia after aspiration with high sensitivity and negative predictive value. Nevertheless, this study does have some limitations as the author had addressed in the text, such as the absence of a gold standard to diagnose bacterial pneumonia and the potential confounding factors. Even though the amylase in BAL has a relatively long-lasting detection window, its dynamic changes of activity should not be neglected. Multiple quantitative detection of BAL amylase would be preferred other than one time measurement. In addition, BAL is an invasive approach which also needs special training before operation, the volume and location of BAL should be standardized to have comparison between different institutes. In some patients without artificial intubation, it is not practical to have BAL examination. Thus, given the current limitations, well-designed Cohort studies should be conducted to test whether this is a robust finding. In conclusion, notwithstanding the caveat, the results from this study may guide the clinical management of aspiration.

Proteomic profiling of bronchoalveolar lavage fluid in children with chronic pulmonary aspiration

Airway Neutrophil Activation and Protease Imbalance in Airway of Children with Foreign-Body Aspiration

Proteome and Dihydrorhodamine Profiling of Bronchoalveolar Lavage in Patients with Chronic Pulmonary Aspergillosis

Chronic Pulmonary Aspiration in Children

LSC Abstract – Early biomarkers indicating the development of neonatal chronic lung disease defined by clinical and imaging parameters

An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease

Parallel accumulation‐serial fragmentation method for in‐depth proteomic analysis of bronchoalveolar lavage fluid collected from patients with nonsmall cell lung cancer

Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.

Amylase in Bronchoalveolar Lavage Fluid: a New Marker for Pulmonary Aspiration.

Metabolomic profiling of exhaled breath condensate for the diagnosis of pulmonary aspergillosis

Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease

Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis

Nasopharyngeal aspirates in children with severe community-acquired pneumonia collected within 3 days before bronchoscopy can partially reflect the pathogens in bronchoalveolar lavage fluids

Microbiology and prognostic factors of hospital- and community-acquired aspiration pneumonia in respiratory intensive care unit.

Novel Proteomic Biomarkers in the Evaluation of Childhood Asthma

Multidisciplinary approach to paediatric aerodigestive disorders: A single-centre longitudinal observational study

Utility of bile acids in large airway bronchial wash versus bronchoalveolar lavage as biomarkers of microaspiration in lung transplant recipients: a retrospective cohort study

Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis

Exhaled Volatile Organic Compounds for Identifying Patients With Chronic Pulmonary Aspergillosis

Proteomic profiling of urinary small extracellular vesicles in children with pneumonia: a pilot study

Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis